{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:39:32Z","timestamp":1794649172733,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82104549"],"award-info":[{"award-number":["82104549"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82104549"],"award-info":[{"award-number":["82104549"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Shanghai Natural Science Foundation of China","award":["23ZR1461200; 22ZR1459400"],"award-info":[{"award-number":["23ZR1461200; 22ZR1459400"]}]},{"name":"Future Plan of Shanghai Medical Innovation and Development Foundation","award":["WL-YBXM-2022002K"],"award-info":[{"award-number":["WL-YBXM-2022002K"]}]},{"name":"Future Plan of Shanghai Medical Innovation and Development Foundation","award":["WL-YBXM-2022002K"],"award-info":[{"award-number":["WL-YBXM-2022002K"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epidemiological studies have indicated a potential link between the gut microbiome and autoimmune liver disease (AILD) such as autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). The relationship between the gut microbiome and autoimmune liver disease is still uncertain due to confounding variables. In our study, we aim to shed light on this relationship by employing a two-sample Mendelian randomization approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a two-sample Mendelian randomization (MR) study using the R package \"TwoSampleMR\". The exposure data consisted of genetic variants associated with 194 bacterial traits obtained from the MiBioGen consortium. Summary statistics for AILD were obtained from the GWAS Catalog website. Furthermore, a series of sensitivity analyses were performed to validate the initial MR results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were two, four and three bacteria traits associated with an increased risk of AIH. PBC, and PSC respectively. In contrast, there were five, two and five bacteria traits associated with a decreased risk for AIH, PBC and PSC. Notably, the\n                      <jats:italic>genus_Clostridium_innocuum_group<\/jats:italic>\n                      showed a negative association with AIH (OR\u2009=\u20090.67, 95% CI: 0.49\u20130.93), and the\n                      <jats:italic>genus_Actinomyces<\/jats:italic>\n                      was found to be genetically associated with a decreased risk of PSC (OR\u2009=\u20090.62, 95% CI: 0.42\u20130.90).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study identified the causal impact of specific bacterial features on the risk of AILD subtypes. Particularly, the\n                      <jats:italic>genus_Clostridium_innocuum_group<\/jats:italic>\n                      and the\n                      <jats:italic>genus_Actinomyces<\/jats:italic>\n                      demonstrated significant protective effects against AIH and PSC respectively. These findings provide further support for the potential use of targeted probiotics in the management of AILD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01670-0","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T08:03:23Z","timestamp":1696320203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"16","author":[{"given":"Yugang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"1670_CR1","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018;4:18017.","journal-title":"Nat Rev Dis Primers"},{"key":"1670_CR2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3350\/cmh.2020.0189","volume":"27","author":"A Komori","year":"2021","unstructured":"Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol. 2021;27:58\u201369.","journal-title":"Clin Mol Hepatol"},{"key":"1670_CR3","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","volume":"68","author":"MH Chapman","year":"2019","unstructured":"Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68:1356\u201378.","journal-title":"Gut"},{"key":"1670_CR4","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70:1989\u20132003.","journal-title":"Gut"},{"key":"1670_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clinre.2014.03.015","volume":"38","author":"N Hadzic","year":"2014","unstructured":"Hadzic N, Hierro L. Autoimmune liver disease: Novelties in management. Clin Res Hepatol Gastroenterol. 2014;38:273\u20136.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1670_CR6","doi-asserted-by":"crossref","first-page":"625913","DOI":"10.3389\/fcimb.2021.625913","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol. 2021;11:625913.","journal-title":"Front Cell Infect Microbiol"},{"key":"1670_CR7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72:558\u201377.","journal-title":"J Hepatol"},{"key":"1670_CR8","doi-asserted-by":"crossref","unstructured":"Cheng Z, Yang L, Chu H. The gut microbiota: a novel player in autoimmune hepatitis. Front Cellular Infect Microbiol. 2022:977.","DOI":"10.3389\/fcimb.2022.947382"},{"key":"1670_CR9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-022-00950-8","volume":"44","author":"D Ellinghaus","year":"2022","unstructured":"Ellinghaus D. How genetic risk contributes to autoimmune liver disease. Semin Immunopathol. 2022;44:397\u2013410.","journal-title":"Semin Immunopathol"},{"key":"1670_CR10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. Jama. 2017;318:1925\u20136.","journal-title":"Jama"},{"key":"1670_CR11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","volume":"44","author":"AGC Boef","year":"2015","unstructured":"Boef AGC, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44:496\u2013511.","journal-title":"Int J Epidemiol"},{"key":"1670_CR12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","volume":"53","author":"A Kurilshikov","year":"2021","unstructured":"Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53:156\u201365.","journal-title":"Nat Genet"},{"key":"1670_CR13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415\u201324.","journal-title":"Nat Genet"},{"key":"1670_CR14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","volume":"75","author":"HJ Cordell","year":"2021","unstructured":"Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, et al. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. J Hepatol. 2021;75:572\u201381.","journal-title":"J Hepatol"},{"key":"1670_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","volume":"49","author":"S-G Ji","year":"2017","unstructured":"Ji S-G, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nat Genet. 2017;49:269\u201373.","journal-title":"Nat Genet"},{"key":"1670_CR16","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"M-JA Brion","year":"2013","unstructured":"Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497\u2013501.","journal-title":"Int J Epidemiol"},{"key":"1670_CR17","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408.","journal-title":"eLife"},{"key":"1670_CR18","unstructured":"SNP Annotation Tool. https:\/\/www.snp-nexus.org\/v4\/. Accessed 2 May 2023."},{"key":"1670_CR19","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","volume":"20","author":"FJ Boehm","year":"2022","unstructured":"Boehm FJ, Zhou X. Statistical methods for Mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J. 2022;20:2338\u201351.","journal-title":"Comput Struct Biotechnol J"},{"key":"1670_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"1670_CR21","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"key":"1670_CR22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"1670_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389.","journal-title":"Eur J Epidemiol"},{"key":"1670_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, et al. The gut\u2013liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1670_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/gutjnl-2014-308514","volume":"64","author":"MH McLean","year":"2015","unstructured":"McLean MH, Dieguez D, Miller LM, Young HA. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut. 2015;64:332\u201341.","journal-title":"Gut"},{"key":"1670_CR26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol. 2019;4:492\u2013503.","journal-title":"Nat Microbiol"},{"key":"1670_CR27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359:1156\u201361.","journal-title":"Science"},{"key":"1670_CR28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","volume":"69","author":"Y Wei","year":"2020","unstructured":"Wei Y, Li Y, Yan LI, Sun C, Miao Q, Wang Q, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69:569\u201377.","journal-title":"Gut"},{"key":"1670_CR29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/hepr.13509","volume":"50","author":"M Furukawa","year":"2020","unstructured":"Furukawa M, Moriya K, Nakayama J, Inoue T, Momoda R, Kawaratani H, et al. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis. Hepatol Res. 2020;50:840\u201352.","journal-title":"Hepatol Res"},{"key":"1670_CR30","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2020.12.058","volume":"160","author":"M Kummen","year":"2021","unstructured":"Kummen M, Thingholm LB, R\u00fchlemann MC, Holm K, Hansen SH, Moitinho-Silva L, et al. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis. Gastroenterology. 2021;160:1784-1798.e0.","journal-title":"Gastroenterology"},{"key":"1670_CR31","doi-asserted-by":"crossref","first-page":"715852","DOI":"10.3389\/fphys.2021.715852","volume":"12","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Ran Y, Zhang H, Wang B, Zhou L. The microbiome in autoimmune liver diseases: Metagenomic and metabolomic changes. Front Physiol. 2021;12:715852.","journal-title":"Front Physiol"},{"key":"1670_CR32","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","volume":"23","author":"L Bajer","year":"2017","unstructured":"Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, et al. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. WJG. 2017;23:4548.","journal-title":"WJG"},{"key":"1670_CR33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","volume":"67","author":"R Tang","year":"2018","unstructured":"Tang R, Wei Y, Li Y, Chen W, Chen H, Wang Q, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut. 2018;67:534\u201341.","journal-title":"Gut"},{"key":"1670_CR34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500:232\u20136.","journal-title":"Nature"},{"key":"1670_CR35","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3389\/fmicb.2018.01995","volume":"9","author":"N Bhaskaran","year":"2018","unstructured":"Bhaskaran N, Quigley C, Paw C, Butala S, Schneider E, Pandiyan P. Role of short chain fatty acids in controlling tregs and immunopathology during mucosal infection. Front Microbiol. 2018;9:1995.","journal-title":"Front Microbiol"},{"key":"1670_CR36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12072-020-10089-z","volume":"15","author":"Y Lapidot","year":"2021","unstructured":"Lapidot Y, Amir A, Ben-Simon S, Veitsman E, Cohen-Ezra O, Davidov Y, et al. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis. Hepatol Int. 2021;15:191\u2013201.","journal-title":"Hepatol Int"},{"key":"1670_CR37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","volume":"14","author":"MN Quraishi","year":"2020","unstructured":"Quraishi MN, Acharjee A, Beggs AD, Horniblow R, Tselepis C, Gkoutos G, et al. A Pilot Integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways. J Crohns Colitis. 2020;14:935\u201347.","journal-title":"J Crohns Colitis"},{"key":"1670_CR38","doi-asserted-by":"crossref","first-page":"656674","DOI":"10.3389\/fcimb.2021.656674","volume":"11","author":"B Rao","year":"2021","unstructured":"Rao B, Lou J, Lu H, Liang H, Li J, Zhou H, et al. Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis. Front Cell Infect Microbiol. 2021;11:656674.","journal-title":"Front Cell Infect Microbiol"},{"key":"1670_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12275-018-8024-4","volume":"56","author":"AJ La Reau","year":"2018","unstructured":"La Reau AJ, Suen G. The Ruminococci: key symbionts of the gut ecosystem. J Microbiol. 2018;56:199\u2013208.","journal-title":"J Microbiol"},{"issue":"Suppl 2","key":"1670_CR40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","volume":"33","author":"O Chazouill\u00e8res","year":"2015","unstructured":"Chazouill\u00e8res O. Overlap syndromes. Dig Dis. 2015;33(Suppl 2):181\u20137.","journal-title":"Dig Dis"},{"key":"1670_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.hbpd.2020.01.003","volume":"19","author":"B-C Rao","year":"2020","unstructured":"Rao B-C, Lou J-M, Wang W-J, Li A, Cui G-Y, Yu Z-J, et al. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2020;19:109\u201315.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1670_CR42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","volume":"66","author":"MC R\u00fchlemann","year":"2017","unstructured":"R\u00fchlemann MC, Heinsen F-A, Zenouzi R, Lieb W, Franke A, Schramm C. Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis. Gut. 2017;66:753\u20134.","journal-title":"Gut"},{"key":"1670_CR43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases. Hepatology. 2020;72:671\u2013722.","journal-title":"Hepatology"},{"key":"1670_CR44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","volume":"60","author":"M Carbone","year":"2014","unstructured":"Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60:210\u201323.","journal-title":"J Hepatol"},{"key":"1670_CR45","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4254\/wjh.v13.i9.1154","volume":"13","author":"R Maslennikov","year":"2021","unstructured":"Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E. Probiotics in hepatology: An update. World J Hepatol. 2021;13:1154.","journal-title":"World J Hepatol"},{"key":"1670_CR46","doi-asserted-by":"crossref","first-page":"108863","DOI":"10.1016\/j.jnutbio.2021.108863","volume":"98","author":"Q Liu","year":"2021","unstructured":"Liu Q, Tian H, Kang Y, Tian Y, Li L, Kang X, et al. Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability. J Nutr Biochem. 2021;98:108863.","journal-title":"J Nutr Biochem"},{"key":"1670_CR47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12964-021-00819-7","volume":"20","author":"L Ma","year":"2022","unstructured":"Ma L, Zhang L, Zhuang Y, Ding Y, Chen J. Lactobacillus improves the effects of prednisone on autoimmune hepatitis via gut microbiota-mediated follicular helper T cells. Cell Commun Signal. 2022;20:83.","journal-title":"Cell Commun Signal"},{"key":"1670_CR48","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","volume":"20","author":"FP Vleggaar","year":"2008","unstructured":"Vleggaar FP, Monkelbaan JF, Van Erpecum KJ. Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study. Eur J Gastroenterol Hepatol. 2008;20:688\u201392.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1670_CR49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s42003-020-01416-z","volume":"3","author":"S Ishida","year":"2020","unstructured":"Ishida S, Kato K, Tanaka M, Odamaki T, Kubo R, Mitsuyama E, et al. Genome-wide association studies and heritability analysis reveal the involvement of host genetics in the Japanese gut microbiota. Commun Biol. 2020;3:686.","journal-title":"Commun Biol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01670-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:20:13Z","timestamp":1700572813000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01670-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1670"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01670-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3020882\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is presented in the mentioned GWAS studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}